Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 16/20 | 0.62 |
| ▸ | ADORA1 | P30542 | 11/20 | 0.62 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.58 |
| ▸ | HSP90B1 | P14625 | 1/20 | 0.56 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29073793 | 1.00 | ADORA3 (0.62) | ADORA3ADORA1ADORA2AHSP90B1ADORA2B | |
| SCHEMBL29762121 | 1.00 | ADORA3 (0.62) | ADORA3ADORA1ADORA2AHSP90B1ADORA2B | |
| SCHEMBL24600612 | 1.00 | ADORA3 (0.62) | ADORA3ADORA1ADORA2AHSP90B1ADORA2B | |
| SCHEMBL29073528 | 0.91 | ADORA3 (0.61) | ADORA3ADORA1ADORA2AHSP90B1ADORA2B | |
| SCHEMBL24600610 | 0.91 | ADORA3 (0.61) | ADORA3ADORA1ADORA2AHSP90B1ADORA2B | |
| SCHEMBL29073625 | 0.91 | ADORA3 (0.61) | ADORA3ADORA1ADORA2AHSP90B1ADORA2B | |
| SCHEMBL24601364 | 0.91 | ADORA3 (0.61) | ADORA3ADORA1ADORA2AHSP90B1ADORA2B | |
| SCHEMBL29762240 | 0.91 | ADORA3 (0.61) | ADORA3ADORA1ADORA2AHSP90B1ADORA2B | |
| SCHEMBL29762083 | 0.91 | ADORA3 (0.61) | ADORA3ADORA1ADORA2AHSP90B1ADORA2B | |
| SCHEMBL29073619 | 0.91 | ADORA3 (0.61) | ADORA3ADORA1ADORA2AHSP90B1ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116783196-A | A3 adenosine receptor agonists, methods of making and uses thereof | 浙江春禾医药科技有限公司 | 2023-09-19 | — | — | CN | claimed |